FATE THERAPEUTICS INC's ticker is FATE and the CUSIP is 31189P102. A total of 240 filers reported holding FATE THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 0.68 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $0 | -100.0% | 319 | -96.6% | 0.00% | – |
Q2 2023 | $44 | -24.1% | 9,441 | -8.7% | 0.00% | – |
Q1 2023 | $58 | +286.7% | 10,336 | +587.2% | 0.00% | – |
Q4 2022 | $15 | -100.0% | 1,504 | +10.2% | 0.00% | – |
Q3 2022 | $30,000 | +650.0% | 1,365 | +689.0% | 0.00% | – |
Q2 2022 | $4,000 | -99.0% | 173 | -98.3% | 0.00% | – |
Q1 2022 | $403,000 | +1579.2% | 10,417 | +2345.3% | 0.00% | – |
Q4 2021 | $24,000 | -96.9% | 426 | -97.8% | 0.00% | -100.0% |
Q3 2020 | $770,000 | +2466.7% | 19,284 | +1121.3% | 0.00% | – |
Q4 2019 | $30,000 | -81.4% | 1,579 | -84.8% | 0.00% | – |
Q3 2019 | $161,000 | -25.8% | 10,388 | -3.2% | 0.00% | -100.0% |
Q2 2019 | $217,000 | -32.8% | 10,730 | -41.7% | 0.00% | 0.0% |
Q1 2019 | $323,000 | +201.9% | 18,413 | +119.4% | 0.00% | – |
Q4 2018 | $107,000 | +10600.0% | 8,394 | +7263.2% | 0.00% | – |
Q3 2018 | $1,000 | -99.3% | 114 | -99.1% | 0.00% | -100.0% |
Q2 2018 | $149,000 | -48.1% | 13,165 | -55.3% | 0.00% | -92.3% |
Q1 2018 | $287,000 | +1095.8% | 29,462 | +637.7% | 0.01% | +1200.0% |
Q4 2017 | $24,000 | – | 3,994 | +3740.4% | 0.00% | – |
Q3 2017 | $0 | – | 104 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
JOHNSON & JOHNSON | 3,379,064 | $7,163,616 | 2.64% |
Redmile Group, LLC | 13,124,427 | $27,823,785 | 1.32% |
Monaco Asset Management SAM | 1,847,944 | $3,917,641 | 1.16% |
Casdin Capital, LLC | 2,050,000 | $4,346,000 | 0.48% |
TANG CAPITAL MANAGEMENT LLC | 700,000 | $1,484,000 | 0.21% |
GCM Grosvenor Holdings, LLC | 495,916 | $1,051,342 | 0.21% |
Nebula Research & Development LLC | 163,617 | $346,868 | 0.18% |
Bellevue Group AG | 4,851,579 | $10,285,347 | 0.17% |
Bruce & Co., Inc. | 200,000 | $424,000 | 0.14% |
XTX Topco Ltd | 192,920 | $408,990 | 0.07% |